Sign In
Buy TEVA
$32.83
-0.250 (-0.756%)
At Close: Jun 03, 2026
Drug, Biotech Stocks' Q2 Earnings on Jul 27: BMY, GSK & More
03:04pm, Tuesday, 26'th Jul 2022 Zacks Investment Research
Let's look what is in store for the four drug, biotech companies slated to release quarterly results tomorrow- BMY, GSK, ALKS, TEVA
Drug, Biotech Stocks' Q2 Earnings on Jul 27: BMY, GSK & More
12:25pm, Tuesday, 26'th Jul 2022
Let's look what is in store for the four drug, biotech companies slated to release quarterly results tomorrow- BMY, GSK, ALKS, TEVA
5 Stocks I'm Betting the Farm On
09:21am, Thursday, 21'st Jul 2022 The Motley Fool
Despite owning 44 stocks, I have 62.5% of my invested assets in just five companies.
5 Stocks I'm Betting the Farm On
05:21am, Thursday, 21'st Jul 2022
Despite owning 44 stocks, I have 62.5% of my invested assets in just five companies.
With Brighter Outlook, Generics Could Be Ripe for Investment
04:26pm, Monday, 18'th Jul 2022
Of the top 10 generic drugmakers in 2021, only one scored an increase in share price during the past year. It was Sun Pharmaceutical Industries Ltd.
San Francisco reaches $54 million opioid settlement with Teva and Allergan
10:27am, Tuesday, 12'th Jul 2022
Teva Pharmaceutical Industries Inc and AbbVie's Allergan business unit reached a $58 million opioid settlement with the city of San Francisco over claims that they fueled an opioid epidemic in the cit
2 Biotech Stocks That Could Soar in the Third Quarter
09:41am, Saturday, 02'nd Jul 2022 The Motley Fool
Bristol Myers Squibb and Bluebird Bio have drugs in their pipelines that could soon earn FDA approval.
Teva to Host Conference Call to Discuss Second Quarter 2022 Financial Results at 8 a.m. ET on July 27, 2022
04:09pm, Wednesday, 29'th Jun 2022
TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter 2022 financial results on Wednesda
2 Buffett Stocks That Outperformed the S&P During the Great Recession
02:37pm, Tuesday, 28'th Jun 2022 The Motley Fool
Are these stocks still good buys today?
2 Buffett Stocks That Outperformed the S&P During the Great Recession
10:37am, Tuesday, 28'th Jun 2022
Are these stocks still good buys today?
AbbVie (ABBV) Files Qulipta sNDA for Chronic Migraine Prevention
02:32pm, Wednesday, 22'nd Jun 2022 Zacks Investment Research
With the latest approval for chronic migraine prevention, AbbVie's(ABBV) Qulipta becomes the only CGRP receptor antagonist approved for a broad preventive treatment of migraine indication.
Teva Pharma Trends Lower Ahead Of A Key Shareholder Meeting This Week
09:54pm, Sunday, 19'th Jun 2022
The Health Care sector has been relatively strong this year amid stock market volatility. Teva Pharmaceuticals struggles with opioid lawsuits, generic drug issues as shares drift lower.
Nasdaq Bear Market: 3 of the Cheapest Stocks You Can Confidently Buy Right Now
09:21am, Wednesday, 15'th Jun 2022 The Motley Fool
These highly profitable stocks are valued at just three to six times Wall Street's forecast earnings for 2023.
Nasdaq Bear Market: 3 of the Cheapest Stocks You Can Confidently Buy Right Now
05:21am, Wednesday, 15'th Jun 2022
These highly profitable stocks are valued at just three to six times Wall Street's forecast earnings for 2023.
Why Is Bausch (BHC) Down 11.2% Since Last Earnings Report?
03:30pm, Thursday, 09'th Jun 2022 Zacks Investment Research
Bausch (BHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
